| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
| mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0002 |
| mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
| mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
0.099 |
0.0009 |
| mRNA |
AUY922 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0009 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0009 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
| mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |